Effects of Bioactive Peptide on Inflammatory Bowel Disease, Focus on Signal Transduction and Intestinal Microbiota.

Abstract:

:Inflammatory Bowel Diseases (IBD) are now widely receiving attention. There are many reasons why people get IBD; for example, environment, smoking, family heredity, intestinal microbiota and so on. Antibiotics have not been proven effective and those suffering from IBD have begun to look for other effective drugs to treat the chronic disease. Bioactive peptides are a good candidate among alternative drugs tested so far, and have been seen to control bodily growth, development, immune regulation and metabolism. This paper will review the literature describing the effects of bioactive peptides on intestinal inflammation. Studies conducted using in vivo models and clinical trials provide evidence that bioactive peptides can be effective in mitigating intestinal inflammation.

journal_name

Curr Pharm Des

authors

Ma Y,Yan W,Ding S,Fei Y,Liu G,Fang J

doi

10.2174/1381612824666180829103945

subject

Has Abstract

pub_date

2018-01-01 00:00:00

pages

2782-2788

issue

24

eissn

1381-6128

issn

1873-4286

pii

CPD-EPUB-92662

journal_volume

24

pub_type

杂志文章,评审
  • Mitochondrial drug targets in cell death and cancer.

    abstract::Mitochondria are involved in different physiological and pathological processes that are crucial for tumor cell physiology, growth and survival. Since cancer cells have frequently disrupted different cell death pathways that promote their survival, mitochondria may be key organelles to promote cell death in cancer cel...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161211796904803

    authors: Ferrín G,Linares CI,Muntané J

    更新日期:2011-01-01 00:00:00

  • The principle and the potential approach to ROS-dependent cytotoxicity by non-pharmaceutical therapies: optimal use of medical gases with antioxidant properties.

    abstract::Regulation of cellular redox balances is important for the homeostasis of human health. Thus, many important human diseases, such as inflammation, diabetes, glaucoma, cancers, ischemia and neurodegenerative diseases, have been investigated in the field of reactive oxygen species (ROS) and oxidative stress. To overcome...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161211797052600

    authors: Noda M,Fujita K,Lee CH,Yoshioka T

    更新日期:2011-01-01 00:00:00

  • Serotonin 5-HT1A Receptors and Antipsychotics - An Update in Light of New Concepts and Drugs.

    abstract::Schizophrenia is characterised by positive, negative, cognitive, depressive and anxiety symptoms. Over the last decades a number of novel treatment strategies with better clinical efficacy and scope, but with lower side-effect profiles have been developed. These have significantly improved the management and prognosis...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612821666150605105215

    authors: McCreary AC,Newman-Tancredi A

    更新日期:2015-01-01 00:00:00

  • Regulation of GABA Neurotransmission by Glutamic Acid Decarboxylase (GAD).

    abstract::Control of GABA neurotransmission at the pre-synaptic site occurs substantially through the activation of the glutamic acid decarboxylase (GAD) enzymes GAD65 and GAD67. Concentrations of GAD65 and GAD67 are controlled either by transcription or by mRNA splicing and importantly the activities of these key enzymes are r...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/1381612821666150917094343

    authors: Modi JP,Prentice H,Wu JY

    更新日期:2015-01-01 00:00:00

  • Safety Profile of the Newest Antiepileptic Drugs: A Curated Literature Review.

    abstract:BACKGROUND:Despite the introduction of new antiepileptic drugs (AEDs), the quality of life and therapeutic response for patients with epilepsy remain unsatisfactory. In addition, whilst several antiepileptic drugs (AEDs) have been approved and consequently marketed in recent years, little is known about their long-term...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612823666170809115429

    authors: Palleria C,Cozza G,Khengar R,Libri V,De Sarro G

    更新日期:2017-01-01 00:00:00

  • Enantiodiscrimination by NMR spectroscopy.

    abstract::The analysis of enantiorecognition processes involves the detection of enantiomeric species as well as the study of chiral discrimination mechanisms. In both fields Nuclear Magnetic Resonance (NMR) spectroscopy plays a fundamental role, providing several tools, based on the use of suitable chiral auxiliaries, for obse...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161206778743628

    authors: Uccello-Barretta G,Balzano F,Salvadori P

    更新日期:2006-01-01 00:00:00

  • Tailoring antiplatelet therapy: a step toward individualized therapy to improve clinical outcome?

    abstract::P2Y12 adenosine di-phosphate (ADP) receptor antagonists are critical to reduce thrombotic recurrences in acute coronary syndromes patients and for those undergoing percutaneous coronary revascularization. Multiple lines of evidence suggest that the level of on-treatment platelet reactivity inhibition with P2Y12 ADP re...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161212803251934

    authors: Laine M,Camoin-Jau L,Bessereau J,Sébastien A,Paganelli F,Bonello L

    更新日期:2012-01-01 00:00:00

  • Approach to new therapeutics: investigation by the use of MDS-derived cell lines.

    abstract::Myelodysplastic syndromes (MDS) are a group of aquired hematopoietic disorders characterized by ineffective hematopoiesis, and increased risk of progression of acute myeloid leukemia. For a long period of time, the standard therapy for MDS was hematopoietic stem cell transplantation, however DNA methyltransferase inhi...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612811209023204

    authors: Tsujioka T,Matsuoka A,Tohyama Y,Tohyama K

    更新日期:2012-01-01 00:00:00

  • Rheumatoid arthritis: genetic variants as biomarkers of cardiovascular disease.

    abstract::Rheumatoid arthritis (RA) is a chronic inflammatory disease associated with premature mortality, severe morbidity, and functional impairment leading to considerable financial burden for both patients and society. Since disease progression and complications can differ from one patient to another, genetic markers are of...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612820666140825123407

    authors: Rodriguez-Rodriguez L,López-Mejias R,Fernández-Gutiérrez B,Balsa A,González-Gay MA,Martín J

    更新日期:2015-01-01 00:00:00

  • Metabolic targets of cardiac hormones' therapeutic anti-cancer effects.

    abstract::The heart is a sophisticated endocrine gland synthesizing a family of peptide hormones by three different genes. These cardiac hormones are stored as 3 prohormones, i.e. atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and C-type natriuretic peptide (CNP) prohormones. Within the ANP prohormones are 4 ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161210790963887

    authors: Vesely DL

    更新日期:2010-01-01 00:00:00

  • Medium-term culture of normal human oral mucosa: a novel three-dimensional model to study the effectiveness of drugs administration.

    abstract::Tissue-engineered oral mucosal equivalents have been developed for in vitro studies for a few years now. However, the usefulness of currently available models is still limited by many factors, mainly the lack of a physiological extracellular matrix (ECM) and the use of cell populations that do not reflect the properly...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/138161212803307482

    authors: Bucchieri F,Fucarino A,Marino Gammazza A,Pitruzzella A,Marciano V,Paderni C,De Caro V,Siragusa MG,Lo Muzio L,Holgate ST,Davies DE,Farina F,Zummo G,Kudo Y,Giannola IL,Campisi G

    更新日期:2012-01-01 00:00:00

  • Natural Antioxidants, Health Effects and Bioactive Properties of Wild Allium Species.

    abstract:BACKGROUND:There is an increasing interest from the pharmaceutical and food industry in natural antioxidant and bioactive compounds derived from plants as substitutes for synthetic compounds. The genus Allium is one of the largest genera, with more than 900 species, including important cultivated and wild species, havi...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612826666200203145851

    authors: Petropoulos SA,Di Gioia F,Polyzos N,Tzortzakis N

    更新日期:2020-01-01 00:00:00

  • Allergic Asthma: A Summary from Genetic Basis, Mouse Studies, to Diagnosis and Treatment.

    abstract::Asthma is an allergic disease that affects approximately 300 million people worldwide. Two of its phenotypes routinely assessed at the clinic include airway hyperresponsiveness and IgE production. They can be measured in a non-invasive manner and have been used for genetic studies. The genetic complexity of asthma and...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612822666160829141708

    authors: Kanagaratham C,Radzioch D

    更新日期:2016-01-01 00:00:00

  • Edible Mushrooms: Novel Medicinal Agents to Combat Metabolic Syndrome and Associated Diseases.

    abstract::Metabolic syndrome is an aggregation of conditions and associated with an increased risk of developing diabetes, obesity and cardiovascular diseases (CVD). Edible mushrooms are widely consumed in many countries and are valuable components of the diet because of their attractive taste, aroma, and nutritional value. Med...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/1381612826666200831151316

    authors: Tung YT,Pan CH,Chien YW,Huang HY

    更新日期:2020-01-01 00:00:00

  • Cancer/testis antigens trigger epithelial-mesenchymal transition and genesis of cancer stem-like cells.

    abstract::Malignant tumors aberrantly overexpress various embryonic genes and proto-oncogenes, including a variety of cancer-testis antigens (CTAs). CTAs belong to a class of testis-derived proteins which are only expressed in germ cells in the male testis, and the expression of CTA genes is entirely silenced in the adult somat...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612821666141211154707

    authors: Yang P,Huo Z,Liao H,Zhou Q

    更新日期:2015-01-01 00:00:00

  • Glucose Sensors Based on Core@Shell Magnetic Nanomaterials and Their Application in Diabetes Management: A Review.

    abstract::This review presents a comprehensive attempt to conclude and discuss various glucose biosensors based on core@shell magnetic nanomaterials. Owing to good biocompatibility and stability, the core@shell magnetic nanomaterials have found widespread applications in many fields and draw extensive attention. Most magnetic n...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612821666150917092528

    authors: Liu L,Lv H,Teng Z,Wang C,Wang G

    更新日期:2015-01-01 00:00:00

  • Subcellular accumulation and modification of pharmaceutical proteins in different plant tissues.

    abstract::Many plant species and tissues have been investigated as production and delivery vehicles for recombinant pharmaceutical proteins. Examples include cultured cells, whole aquatic plants and transgenic plants expressing recombinant proteins in their leaves, seeds, fruits or tubers/roots. Each platform has unique propert...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612811319310005

    authors: Hofbauer A,Stoger E

    更新日期:2013-01-01 00:00:00

  • Potential cardio-protective agents: A Resveratrol review (2000-2019).

    abstract::With a 2030 projection of 23.6 million deaths per year the prevalence and severity of cardiovascular disease is at an astounding high. Thus, a definitive need for the identification of novel compounds with potential to prevent or treat the disease and associated states. Moreover, there is also an ever-increasing need ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/1381612826666200909125354

    authors: Houacine C,Khan I,Yousaf SS

    更新日期:2020-09-09 00:00:00

  • New Approaches for Weight Loss: Experiments Using Animal Models.

    abstract::The number of people who are overweight and obese are continuously increasing both in the adult and adolescent populations. Coinciding with this is the increased prevalence of health problems such as type 2 diabetes (T2D). Bariatric surgery is the only proven long-term treatment of obesity and may induce remission of ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612824666180614075412

    authors: Olsen MK,Johannessen H,Ramracheya R,Zhao CM,Chen D

    更新日期:2018-01-01 00:00:00

  • Runx2/Cbfa1: a multifunctional regulator of bone formation.

    abstract::Runx2/Cbfa/AML3 is a member of the runt homology domain family of transcription factors, essential for osteoblast differentiation and bone formation. Defining the molecular mechanisms by which Runx2 can function as a master regulatory gene for activating the program of osteoblastogenesis has provided novel insights fo...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612033453659

    authors: Lian JB,Stein GS

    更新日期:2003-01-01 00:00:00

  • Regulatory mechanism of the gastric hyperemic response following barrier disruption: roles of cyclooxygenase-1, the prostaglandin E2/EP1 receptor and sensory neurons.

    abstract::We herein reviewed the mechanism underlying the gastric hyperemic response following barrier disruption, with a focus on cyclooxygenase (COX) isozymes, prostaglandin (PG) E2, and capsaicin-sensitive afferent neurons. Mucosal damage was induced by exposing the stomach to 20 mM taurocholate (TC) with 50 mM HCl. The TC t...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612821666150514105248

    authors: Takeuchi K,Takeeda M,Amagase K,Nakashima M

    更新日期:2015-01-01 00:00:00

  • Reactivity of Diterpenoid Quinones: Royleanones.

    abstract::Naturally occurring abietane diterpenoids have been studied over the years and have shown to display a wide range of biological activities. This review covers three main aspects of the abietane-type diterpenoids with hydroxy-p-quinone C ring, designated as royleanones. An overview of 1) the naturally occurrence, 2) ch...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612822666151211094521

    authors: Ladeiras D,Monteiro CM,Pereira F,Reis CP,Afonso CA,Rijo P

    更新日期:2016-01-01 00:00:00

  • Ion Channel and Neurotransmitter Modulators as Electroceutical Approaches to the Control of Cancer.

    abstract::The activities of individual cells must be tightly coordinated in order to build and maintain complex 3- dimensional body structures during embryogenesis and regeneration. Thus, one way to view cancer is within systems biology as a network disorder affecting the ability of cells to properly interact with a morphodynam...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612823666170530105837

    authors: Tuszynski J,Tilli TM,Levin M

    更新日期:2017-01-01 00:00:00

  • Systemic Allergy to Corticosteroids: Clinical Features and Cross Reactivity.

    abstract::Systemic hypersensitivity (HS) to corticosteroids (CS) is paradoxical but does exist. Some patients with a previous contact allergy to topical CS may develop a systemic contact dermatitis (SCD) while receiving CS orally or intravenously. However, a previous contact sensitization is not mandatory for developing a syste...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612822666161013092339

    authors: Barbaud A,Waton J

    更新日期:2016-01-01 00:00:00

  • GnRH in the treatment of Hypogonadotropic hypogonadism.

    abstract::Gonadotropin Releasing Hormone (GnRH) is at the centre of the scientific debate for the treatment of hypogonadotropic hypogonadism. Sexual maturation and reproductive function depend on the pulsatile secretion of GnRH are mainly congenital and may or may not be associated with other genetic anomalies or syndromes. Cli...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/1381612826666201125113319

    authors: Bettocchi C,Rinaldi M,Sebastiani F

    更新日期:2020-11-24 00:00:00

  • Cellular protection and therapeutic potential of tocotrienols.

    abstract::Tocotrienols, components belonging to vitamin E members, are used as potent therapeutics in the treatment of several diseases. Recent studies suggested tocotrienol to have better activity in many situations compared to tocopherols. Tocotrienols have been shown to lower the atherogenic apolipoprotein B and lipoprotein ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161211796957436

    authors: Catalgol B,Batirel S,Ozer NK

    更新日期:2011-01-01 00:00:00

  • Adrenal Hyperandrogenism and Polycystic Ovary Syndrome.

    abstract:BACKGROUND:The prevalence of adrenal hyperandrogenism (AH), as defined by increased circulating dehydroepiandrosterone-sulfate (DHEAS) levels, ranges from 15 to 45% in women with polycystic ovary syndrome (PCOS). METHODS:The aim of this review is to update the pathogenesis and consequences of AH in PCOS, from molecula...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612822666160720150625

    authors: Luque-Ramírez M,Escobar-Morreale HF

    更新日期:2016-01-01 00:00:00

  • Identification of the descriptor pharmacophores using variable selection QSAR: applications to database mining.

    abstract::The pharmacophore concept is central to the rational drug design and discovery process. Traditionally, a pharmacophore is defined as a specific three-dimensional (3D) arrangement of chemical functional groups found in active molecules, which are characteristic of a certain pharmacological class of compounds. Herein, b...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612013397834

    authors: Tropsha A,Zheng W

    更新日期:2001-05-01 00:00:00

  • Pharmacological Treatments for Fragile X Syndrome Based on Synaptic Dysfunction.

    abstract:BACKGROUND:Fragile X syndrome (FXS) is the most common form of monogenic hereditary cognitive impairment, including intellectual disability, autism, hyperactivity, and epilepsy. METHODS:This article reviews the literature pertaining to the role of synaptic dysfunction in FXS. RESULTS:In FXS, synaptic dysfunction alte...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612825666191102165206

    authors: Telias M

    更新日期:2019-01-01 00:00:00

  • Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i): Their Role in Cardiometabolic Risk Management.

    abstract:BACKGROUND:Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are a novel category of oral antidiabetic drugs that inhibit renal glucose reabsorption and increase renal glucose excretion, thus lowering plasma glucose levels. This unique mechanism of SGLT2i action is insulin independent, thus improving glycemic control ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612823666170113152742

    authors: Katsiki N,Mikhailidis DP,Theodorakis MJ

    更新日期:2017-01-01 00:00:00